Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prashanth Ashok Kumar

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|April 2, 2023
Intestinal barrier functions in hematologic and oncologic diseasesElio Haroun, Prashanth Ashok Kumar, Ludovic Saba, et al.
Life Sciences|October 29, 2022
Radioimmunoconjugates in the age of modern immuno-oncologyDayana Nasr, Prashanth Ashok Kumar, Maroun Bou Zerdan, et al.
European Journal of Haematology|October 30, 2023
Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United StatesPrashanth Ashok Kumar, Krishna Ghimire, Elio Haroun, et al.
Breast Cancer Research and Treatment|January 18, 2025
A meta-analysis of the utility of cryotherapy for preventing peripheral neuropathy among breast cancer patients receiving paclitaxel and nab-paclitaxelPrashanth Ashok Kumar, Parth Sampat, Michael Sandhu, et al.
Frontiers in Oncology|July 5, 2023
Genomic landscape of clinically advanced <i>KRAS</i> wild-type pancreatic ductal adenocarcinomaPrashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, et al.
Cancer Medicine|June 24, 2022
Genomic landscape of non-small-cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiencyPrashanth Ashok Kumar, Stephen L Graziano, Natalie Danziger, et al.
Cancer Medicine|December 14, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast CancerAbirami Sivapiragasam, Prashanth Ashok Kumar, Ethan S Sokol, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
NPJ Breast Cancer|May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy resultsKristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Frontiers in Oncology|May 30, 2023
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancerMaroun Bou Zerdan, Prashanth Ashok Kumar, Dulce M Barrios, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|April 2, 2023
Intestinal barrier functions in hematologic and oncologic diseasesElio Haroun, Prashanth Ashok Kumar, Ludovic Saba, et al.
Life Sciences|October 29, 2022
Radioimmunoconjugates in the age of modern immuno-oncologyDayana Nasr, Prashanth Ashok Kumar, Maroun Bou Zerdan, et al.
European Journal of Haematology|October 30, 2023
Utilization and outcome disparities in allogeneic hematopoietic stem cell transplant in the United StatesPrashanth Ashok Kumar, Krishna Ghimire, Elio Haroun, et al.
Breast Cancer Research and Treatment|January 18, 2025
A meta-analysis of the utility of cryotherapy for preventing peripheral neuropathy among breast cancer patients receiving paclitaxel and nab-paclitaxelPrashanth Ashok Kumar, Parth Sampat, Michael Sandhu, et al.
Frontiers in Oncology|July 5, 2023
Genomic landscape of clinically advanced <i>KRAS</i> wild-type pancreatic ductal adenocarcinomaPrashanth Ashok Kumar, Serenella Serinelli, Daniel J Zaccarini, et al.
Cancer Medicine|June 24, 2022
Genomic landscape of non-small-cell lung cancer with methylthioadenosine phosphorylase (MTAP) deficiencyPrashanth Ashok Kumar, Stephen L Graziano, Natalie Danziger, et al.
Cancer Medicine|December 14, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast CancerAbirami Sivapiragasam, Prashanth Ashok Kumar, Ethan S Sokol, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
NPJ Breast Cancer|May 20, 2026
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy resultsKristina Fanucci, Mariya Rozenblit, Julia C F Quintanilha, et al.
Frontiers in Oncology|May 30, 2023
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancerMaroun Bou Zerdan, Prashanth Ashok Kumar, Dulce M Barrios, et al.
Pageof 5